Changes in energy metabolism and X-ray sensitivity in murine tumours by the nitric oxide donor SIN-1

P J Wood1, J M Sansom, I J Stratford

  • 1MRC Radiobiology Unit, Chilton, Didcot, Oxon, UK.

Insights

Nitric oxide (NO) donor SIN-1 impacts tumor energy metabolism and X-ray sensitivity. Responses vary with NO donor dose, administration timing, and specific tumor type, suggesting potential for tailored cancer therapies.

Area of Science:

  • Biomedical sciences
  • Oncology
  • Radiotherapy

Background:

  • Nitric oxide (NO) plays a complex role in cancer biology.
  • Understanding NO donor effects on tumor metabolism and treatment response is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the impact of the NO donor SIN-1 on energy metabolism in murine tumors.
  • To evaluate the effect of SIN-1 on tumor response to X-ray irradiation in vivo.

Main Methods:

  • Utilized 31P magnetic resonance spectroscopy (MRS) to assess energy metabolism in vivo.
  • Employed an in vivo/in vitro clonogenic assay to determine tumor cell killing post-irradiation.

Main Results:

  • SIN-1 (2 mg/kg) reduced Pi/total ratio in SCCVII/Ha and KHT tumors, but not consistently in RIF-1 tumors.
  • Low-dose SIN-1 (0.5-2 mg/kg) given before irradiation enhanced tumor cell killing 2-4 fold.
  • Higher SIN-1 doses showed delayed effects on Pi/total or were ineffective in enhancing X-ray response.

Conclusions:

  • NO donors like SIN-1 can modulate tumor energy metabolism and radiosensitivity.
  • These effects are dependent on the dose of SIN-1, timing of administration, and the specific tumor type.
  • Findings suggest NO donors may enhance tumor oxygenation, impacting treatment outcomes.

Related Concept Videos